News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OPX Biotechnologies Secures $12.1 Million Third Round Financing


2/12/2009 8:09:44 AM

OPX Biotechnologies Inc., a Boulder, Colo.-based company focused on improving the viability and cost-effectiveness of biofuels and biorefined chemicals, has secured around $12.1 million of a $17.5 million third round of VC funding, according to a regulatory filing.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES